Ticker Scorecard - COGT Basics Company: Cogent Biosciences, Inc. IPO Date: March 26, 2018 Sector: Healthcare Industry: Biotech Market Cap: $883.69M Activated in VL: True Average Daily Range Avg Daily Range: $0.28 | 3.19% Avg Daily Range (30 D): $0.20 | 2.36% Avg Daily Range (90 D): $0.23 | 2.46% Institutional Daily Volume Avg Daily Volume: .5M Avg Daily Volume (30 D): 1.19M Avg Daily Volume (90 D): 1.21M Trade Size Avg Trade Size (Sh.): 107 Avg Trade Size (Sh.) (30 D): 99 Avg Trade Size (Sh.) (90 D): 105 Institutional Trades Total Inst.Trades: 1,384 Avg Inst. Trade: $1.61M Avg Inst. Trade (30 D): $1.47M Avg Inst. Trade (90 D): $1.49M Avg Inst. Trade Volume: .17M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.76M Avg Closing Trade (30 D): $1.1M Avg Closing Trade (90 D): $1.4M Avg Closing Volume: 182.99K     News Jun 28, 2024 @ 1:18 PM Cogent (COGT) Up on SUMMIT Study Update Post Posit... Source: Zacks Equity Research Jun 14, 2024 @ 11:30 AM Cogent Biosciences Announces Additional Clinical D... Source: Cogent Biosciences, Inc. May 23, 2024 @ 9:05 PM Cogent Biosciences Appoints Cole Pinnow as Chief C... Source: Cogent Biosciences, Inc. May 23, 2024 @ 9:01 PM Cogent Biosciences Announces Positive Updated Lead... Source: Cogent Biosciences, Inc. Apr 15, 2024 @ 12:19 PM Marinus Pharmaceuticals, Neumora Therapeutics And ... Source: Avi Kapoor Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.64 $-.59 $-.62 Diluted EPS $-.64 $-.59 $-.62 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -70.63M $ -58.95M $ -58.35M Operating Income / Loss $ -75.41M $ -64.39M $ -62.4M Cost of Revenue $ $ $ Net Cash Flow $ 8.83M $ -127.58M $ 162.57M PE Ratio     Splits Nov 09, 2020:   4:1